Stage
IPOTotal Raised
$108.57MInvestors Count
14Deal Terms
4Portfolio Exits
1Abzena Funding, Abzena Valuation & Abzena Revenue
11 Fundings
Abzena's latest funding round was a Unattributed VC - II for $65M on March 31, 2022.
Abzena's valuation in September 2018 was $43.77M.
Abzena's latest post-money valuation is from September 2018.
Sign up for a free trial to see Abzena's valuations in July 2014 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/31/2022 | Unattributed VC - II | $65M | Biospring Partners, Undisclosed Investors, and WCAS | 3 | ||
7/28/2020 | Unattributed VC | $10M | 3 | |||
9/3/2018 | Take Private | ▼$43.77M | 4 | |||
7/23/2014 | IPO | |||||
7/29/2013 | Merger |
Date | 3/31/2022 | 7/28/2020 | 9/3/2018 | 7/23/2014 | 7/29/2013 |
|---|---|---|---|---|---|
Round | Unattributed VC - II | Unattributed VC | Take Private | IPO | Merger |
Amount | $65M | $10M | |||
Investors | Biospring Partners, Undisclosed Investors, and WCAS | ||||
Valuation | ▼$43.77M | ||||
Revenue | |||||
Sources | 3 | 3 | 4 |
Abzena Deal Terms
4 Deal Terms
Abzena's deal structure is available for 4 funding rounds, including their Take Private from September 03, 2018.
Round | Take Private | IPO | Series B | Series A |
|---|---|---|---|---|
Funding Date | ||||
Pre-Money Valuation | ||||
Post-Money Valuation | ||||
Amount Raised | ||||
Shares Authorized | ||||
Issuance Price | ||||
Dividend Rate | ||||
Liquidation Preferences | ||||
Liquidation Price | ||||
Participation | ||||
Conversion Price | ||||
Anti Dilution | ||||
General Voting | ||||
Board Voting | ||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Take Private | |||||||||||||||
IPO | |||||||||||||||
Series B | |||||||||||||||
Series A |
Abzena Investors
14 Investors
Abzena has 14 investors. Biospring Partners invested in Abzena's Unattributed VC - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/28/2020 | 3/31/2022 | 2 Unattributed VC, Unattributed VC - II (2022) | Venture Capital | New York | ||
3/31/2022 | 3/31/2022 | 1 Unattributed VC - II | Private Equity | New York | ||
9/3/2018 | 9/3/2018 | 1 Take Private | Private Equity | New York | ||
Venture Capital | United Kingdom | |||||
Private Equity | United Kingdom |
First funding | 7/28/2020 | 3/31/2022 | 9/3/2018 | ||
|---|---|---|---|---|---|
Last Funding | 3/31/2022 | 3/31/2022 | 9/3/2018 | ||
Investor | |||||
Rounds | 2 Unattributed VC, Unattributed VC - II (2022) | 1 Unattributed VC - II | 1 Take Private | ||
Board Seats | |||||
Type | Venture Capital | Private Equity | Private Equity | Venture Capital | Private Equity |
Location | New York | New York | New York | United Kingdom | United Kingdom |
Abzena Acquisitions
4 Acquisitions
Abzena acquired 4 companies. Their latest acquisition was The Chemistry Research Solution on November 24, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
11/24/2015 | Acquired | 3 | ||||
9/14/2015 | ||||||
7/29/2013 | ||||||
7/29/2013 | Other Venture Capital |
Date | 11/24/2015 | 9/14/2015 | 7/29/2013 | 7/29/2013 |
|---|---|---|---|---|
Investment Stage | Other Venture Capital | |||
Companies | ||||
Valuation | ||||
Total Funding | ||||
Note | Acquired | |||
Sources | 3 |
Abzena Portfolio Exits
1 Portfolio Exit
Abzena has 1 portfolio exit. Their latest portfolio exit was Abzena on July 23, 2014.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.